SANDOZ GLYBURIDE DIN 02248009
Health Canada record
| Active ingredient(s) | GLYBURIDE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A10BB01 GLIBENCLAMIDE |
| Original market date | 13-Aug-2003 |
| Current status date | 01-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GLYBURIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01913654 | APO GLYBURIDE TAB 2.5MG | APOTEX INC | Tablet | GLYBURIDE 2.5 MG | Marketed |
| 01913662 | APO GLYBURIDE TAB 5MG | APOTEX INC | Tablet | GLYBURIDE 5 MG | Marketed |
| 01913670 | TEVA-GLYBURIDE | TEVA CANADA LIMITED | Tablet | GLYBURIDE 2.5 MG | Marketed |
| 01913689 | TEVA-GLYBURIDE | TEVA CANADA LIMITED | Tablet | GLYBURIDE 5 MG | Marketed |
| 02363712 | AVA-GLYBURIDE | AVANSTRA INC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02363704 | AVA-GLYBURIDE | AVANSTRA INC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02224550 | DIABETA | SANOFI-AVENTIS CANADA INC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02224569 | DIABETA | SANOFI-AVENTIS CANADA INC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 00012599 | DIABETA 5MG | HOECHST CANADA INC. | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 00454753 | DIABETA TAB 2.5MG | HOECHST CANADA INC. | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 01987836 | DIABETA TAB 5MG | HOECHST ROUSSEL CANADA INC. | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 01987534 | DIABETA TABLETS 2.5MG | HOECHST ROUSSEL CANADA INC. | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02234513 | DOM-GLYBURIDE | DOMINION PHARMACAL | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02234514 | DOM-GLYBURIDE | DOMINION PHARMACAL | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 00720933 | EUGLUCON | PHARMASCIENCE INC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 00720941 | EUGLUCON | PHARMASCIENCE INC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02485664 | GLYBURIDE | PRO DOC LIMITEE | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 01959352 | GLYBURIDE | PRO DOC LIMITEE | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02350467 | GLYBURIDE | SANIS HEALTH INC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02350459 | GLYBURIDE | SANIS HEALTH INC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02230036 | GLYBURIDE TABLETS 2.5MG | PREMPHARM INC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02230037 | GLYBURIDE TABLETS 5MG | PREMPHARM INC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 01959360 | GLYBURIDE-5 TAB 5MG | PRO DOC LIMITEE | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02084341 | MED GLYBE TAB 2.5MG | MEDICAN PHARMA INCORPORATED | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02085887 | MED GLYBE TAB 5MG | MEDICAN PHARMA INCORPORATED | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 00808741 | MYLAN-GLYBE | MYLAN PHARMACEUTICALS ULC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 00808733 | MYLAN-GLYBE | MYLAN PHARMACEUTICALS ULC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02345854 | NTP-GLYBURIDE | TEVA CANADA LIMITED | Tablet | GLYBURIDE 2.5 MG | Cancelled Pre Market |
| 02345862 | NTP-GLYBURIDE | TEVA CANADA LIMITED | Tablet | GLYBURIDE 5 MG | Cancelled Pre Market |
| 02020734 | NU-GLYBURIDE TAB 2.5MG | NU-PHARM INC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02020742 | NU-GLYBURIDE TAB 5MG | NU-PHARM INC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02229595 | PENTA-GLYBURIDE - 2.5MG | PENTAPHARM LTD. | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02229596 | PENTA-GLYBURIDE - 5MG | PENTAPHARM LTD. | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02236733 | PMS-GLYBURIDE | PHARMASCIENCE INC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02236734 | PMS-GLYBURIDE | PHARMASCIENCE INC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02316544 | PRO-GLYBURIDE | PRO DOC LIMITEE | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 01900935 | RATIO-GLYBURIDE | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 01900927 | RATIO-GLYBURIDE | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02242096 | RIVA-GLYBURIDE | LABORATOIRE RIVA INC. | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02242095 | RIVA-GLYBURIDE | LABORATOIRE RIVA INC. | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02236548 | RIVA-GLYBURIDE | PHARMEL INC | Tablet | GLYBURIDE 5 MG | Cancelled Post Market |
| 02236543 | RIVA-GLYBURIDE | PHARMEL INC | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
| 02248008 | SANDOZ GLYBURIDE | SANDOZ CANADA INCORPORATED | Tablet | GLYBURIDE 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7767 | 2006-02-17 | New Drug Submission (NDS) | NEW MANUFACTURER AND PRODUCT NAME |
| 950 | 2003-08-01 | New Drug Submission (NDS) | NEW MANUFACTURER AND PRODUCT NAME |
International API supply for GLYBURIDE
9 active FDA Drug Master Files.
Request a quote for SANDOZ GLYBURIDE